Medtronic plc (MDT) stock
Close on Nov 11, 2026Market cap $129.97BP/E 25.0Yield 2.79%
Medtronic plc grew revenue 9.8% to $37.54B over the twelve months to Jul 31, 2026. Operating income rose 10.9% to $6.79B, moving the operating margin from 17.9% to 18.1%. Free cash flow was $6.13B, up 15.6% from a year earlier. At the latest close the market valued the company at $129.97B, 25.0 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 31, 2026
Valuation
- Market cap
- $129.97B
- P/E ratio
- 25.0
- Price to sales
- 3.46
- Price to book
- 2.59
- Dividend yield
- 2.79%
- Free cash flow yield
- 4.72%
Fundamentals
- Revenue
- $37.54B
- Net income
- $5.23B
- EPS, diluted
- $4.07
- Free cash flow
- $6.13B
- Book value per share
- $39.09
- Diluted shares
- 1.29B
Trading
- Next earnings
- Nov 17, 2026 (estimated, before the open)
- Previous close
- $101.59
- Open
- $100.70
- Day's range
- $100.02 – $101.81
- Volume
- 4,389,370
- Average volume (20 days)
- 12,388,480
- Index membership
- S&P 500 (since Dec 2019), Russell 1000 (since Sep 2022)
- Beta (5 years)
- 0.50
- 52-week range
- $73.31 – $106.33
- RSI (14 days)
- 61.9
- Volatility (1 year)
- 25.7%
- Relative volume
- 0.32×
- WACC
- 6.8%
On 1 of our idea list: Dividend growers
Index membership is inferred from the holdings of funds that track each index (VOO, IWB), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2013, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | MDT | S&P 500 | Difference | MDT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +14.8% | -2.4% | +17.2 pts | ||
| 3 months | +13.0% | -1.2% | +14.1 pts | ||
| Year to date | +8.5% | +12.3% | −3.8 pts | ||
| 1 year | +10.0% | +12.4% | −2.4 pts | ||
| 3 years | +58.6% | +78.8% | −20.2 pts | +16.6% | +21.4% |
| 5 years | -0.3% | +75.2% | −75.5 pts | -0.1% | +11.9% |
| 10 years | +61.3% | +311.1% | −249.8 pts | +4.9% | +15.2% |
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Medtronic filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Results
- Update
- Results
- Results
About Medtronic
Electromedical & Electrotherapeutic Apparatus
Medtronic plc is a global healthcare technology enterprise that engineers, manufactures, and markets device-based therapies and medical solutions. The company operates primarily through three core portfolios: Cardiovascular, Neuroscience, and Medical Surgical. Its offerings encompass cardiac pacemakers, defibrillators, ablation catheters, heart valves, and stent grafts, as well as cranial and spinal implants, surgical navigation, robotic guidance systems, neurostimulators, and drug delivery devices. Additionally, it provides advanced surgical tools, electrosurgical instruments, hernia meshes, and patient monitoring and airway management equipment. Medtronic supplies its products to healthcare systems, hospitals, ambulatory surgery centers, physician clinics, and specialized medical professionals across numerous clinical disciplines.
Company profile, executives and historyMedtronic stock: common questions
What is Medtronic's stock price?
MDT closed at $101.61 on Nov 11, 2026, up 0.02% on the day. Over the past 52 weeks it traded between $73.31 and $106.33.
What is Medtronic's market cap?
Medtronic was worth $129.97B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is MDT's P/E ratio?
MDT trades at 25.0 times earnings, based on diluted earnings per share of $4.07 over the twelve months to Jul 31, 2026.
How much revenue does Medtronic make?
Medtronic reported revenue of $37.54B for the twelve months to Jul 31, 2026, up 9.8% from a year earlier.
Does Medtronic pay a dividend?
Yes. Medtronic paid $2.84 per share over the last twelve months, a yield of 2.79% at the latest price, and has raised its annual dividend 13 years in a row.
When does Medtronic report earnings next?
Medtronic is expected to report Q2 FY2027 results on Nov 17, 2026, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has MDT stock performed over the past year?
Including dividends, MDT returned +10.0% over the past year, against +12.4% for the S&P 500.
How many MDT shares are sold short?
23M shares were sold short at the latest FINRA report, 1.80% of the float, or 1.9 days of average trading volume.
Who are Medtronic's competitors?
Companies most similar to Medtronic by business, industry and size include BSX, BAX, BDX, SYK, GEHC.
See a number that looks wrong?